Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 12—December 2003
Research

Multidrug-resistant Mycobacterium tuberculosis in HIV-Infected Persons, Peru

Pablo E. Campos*†, Pedro G. Suarez‡§, Jorge Sanchez†, David Zavala‡, Jorge Arevalo‡, Eduardo Ticona‡, Charles M. Nolan*¶, Thomas M. Hooton*, and King K. Holmes*Comments to Author 
Author affiliations: *University of Washington, Seattle, Washington, USA; †Cayetano Heredia University, Lima, Peru; ‡Peruvian Ministry of Health, Lima-Peru; §Asociacion Civil Impacta Salud y Educacion (IMPACTA), Lima, Peru; ¶Public Health Seattle-King County, Seattle, Washington, USA

Main Article

Table 3

Demographic characteristics, past medical history, and potential exposures to TB of HIV-infected participants with MDR-TB and without MDR-TBa

Variable HIV-infected with MDR-TB (n = 35) HIV-infected without MDR-TB (n = 46) OR (95% CI) p value
Mean ± SD or %
 Mean ± SD or %
Employedb
 46
 76
0.3 (0.1 to 0.7)
Exposure to TB at workc
 6
 26
0.2 (0.04 to 0.8)
Exposure to TB at homec
 20
 13
1.7 (0.5 to 5.5)
Previously treated TBd
 29
 26
1.1 (0.4 to 3.0)
Duration of symptoms
 6.7 ± 5.4
 7.8 ± 6.6
 0.44
Ambulatory care at health centersb
 14
 26
0.5 (0.2 to 1.5)
Ambulatory care at hospitalsb
 43
 37
1.3 (0.5 to 3.1)
Ambulatory care at hospitalse
 3924 ± 5749
 2737 ± 3361
 0.48
Inpatient careb
 17
 11
1.7 (0.5 to 6.1)
Inpatient MoH hospitalsb
 11
 11
1.1 (0.3 to 4.3)
Days of hospitalizationb
 18 ± 11
 30 ± 26
 0.36
Diagnosed at hospital “A”
 80
 52
3.7 (1.3 to 10)
Any exposure to hospitalb
 51
 39
1.6 (0.7 to 4.0)
HIV support groupb
 11
 7
1.9 (0.4 to 8.9)
TB prophylaxisd
 26
 20
1.4 (0.5 to 4.1)
Mo. TB prophylaxis
 6.7 ± 5
 4.4 ± 3.3
 0.27
PCP prophylaxisd
 57
 44
1.7 (0.7 to 4.2)
Extrapulmonary TB 29 44 0.5 (0.2 to 1.3)

aMDR-TB, multidrug-resistant tuberculosis; OR, odds ratio; CI, confidence interval; MoH, Ministry of Health; PCP, Pneumocystis carinii pneumonia.
bVariables reported by patients to have occurred 12 months before onset of symptoms.
cExposure to someone with TB at work or at home 12 months before onset of symptoms.
dEver in the past.
eAs a continuous variable: total minutes of exposure 12 months before onset of symptoms.

Main Article

Page created: February 07, 2011
Page updated: February 07, 2011
Page reviewed: February 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external